
Professor and consultant in Renal Medicine #KidneyDoctor Passionate about cardiovascular complications of CKD and #kidneyeducation
London UK
Joined August 2019
- Tweets330
- Following22
- Followers354
- Likes1.5K
Debasish Banerjee retweeted
#EventHighlight #GHRCSymposium2026
Dr. Vivekanand Jha shares valuable insights on the different aspects of #researchimpact and the importance of creating actionable, affordable interventions at the nexus of #noncommunicablediseases and #climatechange.
Very pleased to announce the first recruited for HOME CHF study!
lnkd.in/eNC8T3Vt
Funded by NIHR
lnkd.in/eqi9JN2V
Optimizing Cardiovascular-Kidney-Metabolic Care With Interdisciplinary Insights medscape.org/viewarticle/100… via @MedscapeCME
Debasish Banerjee retweeted
A huge thank you to all the speakers, moderators, attendees, and supporters who made the ISN’s multidisciplinary Expert Forum, Exploring the Nexus of Cardio-Kidney-Metabolic Health, a success. The event took place from October 17–18 in Amsterdam 🇳🇱
Understanding Cardiac Troponins in Kidney Disease | ECR Journal ecrjournal.com/articles/card…
Debasish Banerjee retweeted
8️⃣.2️⃣ Optimization of SGLT2i Therapy Toolkit: The second in a joint cardio-nephrology series, featuring educational and clinical infographics to support SGLT2i therapy use: lite.spr.ly/6006Hy44
Thanks everyone who helped us manage CKD and HF patients at home @geshNHS @CityStGeorges @ISNkidneycare @UKKidney bmjopenquality.bmj.com/conte…
Debasish Banerjee retweeted
Honored to present on disruptive change in Vascular Access at the Vascular Access Society meeting in Padua, Italy.
Wonderful to meet old friends
@UNCDeptMedicine
Debasish Banerjee retweeted
STARTING NOW HIT! High Impact Clinical Trials – Study Design
🕗 11 am
🗣️ @adeeralevin , Hernán Trimarchi, @jardine_meg , @debukidney
👥@Dilushiwijay , Jaiprakash Tiwari
📍Brahmkamal Hall - Plenary Hall
#ISNWCN
Debasish Banerjee retweeted
ISN manifesto
What do we do next?
#ISNWCN
Debasish Banerjee retweeted
Thank you very much for the invitation @proychaudhuryMD - honored to be included with such august company! A truly memorable evening-enjoyed the fun conversations & the futuristic perspectives of leaders in nephrology! And being in Delhi was the icing on the cake🥰@ISNWCN #ISNWCN
A very special and very proud feeling to host friends from around the world in my hometown of Delhi @ISNWCN
Debasish Banerjee retweeted
Co-Chaired a session with @debukidney on Renal Resilience - Recent Advances in Clinical Knowledge and Future Treatment of Rare Orphan Diseases with the likes of @KSusztak @ariela_benigni @ClaireSharpe22 & Yaacov Frishberg, at the World Congress of Nephrology in New Delhi #ISNWCN
Wandsworth Council gives green light on plans to build one of the UK’s largest kidney units - St George's University Hospitals NHS Foundation Trust stgeorges.nhs.uk/newsitem/wa… via @StGeorgesTrust @geshNHS @CityUniLondon
Debasish Banerjee retweeted
SGLT2 Inhibitor #SGLT2i in #Diabetic and #NonDiabetic Renal #Transplant Recipients
#VisualAbstract by @DrPSVali
kireports.org/article/S2468-…
Excellent opportunity for a PhD on "At home furosemide in CKD Heart failure patients, a RCT and large data analysis" through St George's PhD Programme @StGeorgesUni sgul.ac.uk/study/postgraduat… @UKKidney @StGeorgesUni @geshNHS @ISNkidneycare
Debasish Banerjee retweeted
😳Monitoring after starting RAASi
@ISNkidneycare @goKDIGO
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - The Lancet Diabetes & Endocrinology thelancet.com/journals/landi…
Stanniocalcin-1: A Novel Mediator in Diabetic Kidney Disease and Cardiovascular Disease - Kidney International Reports kireports.org/article/S2468-…
Another treatment for HFpEF Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…

























